The sale was non-discretionary to cover tax liabilities from restricted stock units vesting, with the CEO retaining 590,777 shares.
Cellebrite DI Ltd. (NASDAQ:DI) CEO Thomas Hogan sold 103,000 shares on July 2, 2026, for $1.6 million at a weighted-average price of $15.76. The transaction was required to fulfill tax obligations tied to the vesting of restricted stock units granted in September 2025.
Following the sale, Hogan retains 590,777 shares, equivalent to a 0.24% ownership stake. The company’s stock has delivered a 3% total return over the past 12 months, closing at $15.65 on the transaction date. Cellebrite reported trailing twelve-month revenue of $496.4 million and net income of $71.9 million, with a market capitalization of $4.1 billion as of July 6, 2026.